Related Experiment Video

Updated: Nov 7, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

984

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy

Ryan Wallace1, Hugh Calkins1

  • 1Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institute, Baltimore, MD, US.

Arrhythmia & Electrophysiology Review
|May 3, 2021
PubMed

Insights

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart condition causing fibrofatty tissue replacement of heart muscle. This review focuses on risk stratification factors for ventricular arrhythmia and sudden cardiac death in ARVC patients.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic cardiac disease.
  • It involves progressive myocyte loss and fibrofatty tissue replacement in the ventricles.
  • ARVC leads to ventricular arrhythmias and a high risk of sudden cardiac death (SCD).

Purpose of the Study:

  • To review literature on risk stratification factors in ARVC patients.
  • To emphasize the importance of determining and stratifying patient risk for ventricular arrhythmia and SCD.
  • To discuss the role and complications of implantable cardioverter-defibrillators (ICDs) in managing ARVC.

Main Methods:

  • Literature review of studies on ARVC.
  • Analysis of factors contributing to risk assessment in ARVC.
  • Examination of clinical outcomes and management strategies.

Main Results:

  • Identification of key factors for assessing ventricular arrhythmia and SCD risk in ARVC.
  • Discussion of the benefits and risks associated with ICD implantation in ARVC patients.
  • Highlighting the need for comprehensive risk stratification.

Conclusions:

  • Accurate risk stratification is crucial for managing ARVC patients.
  • ICDs are vital for preventing SCD but carry inherent complications.
  • Further research into risk stratification factors can optimize ARVC patient care.

Keywords:
Arrhythmogenic right ventricular cardiomyopathyICDcardiomyopathyright ventricular dysplasiarisk stratificationsudden cardiac deathventricular arrhythmia

More Related Videos

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.2K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.5K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
162
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
179
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
117
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
118
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
173
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
102